Logo image of HLN

HALEON PLC-ADR (HLN) Stock Overview

NYSE:HLN - US4055521003 - ADR

9.63 USD
-0.05 (-0.52%)
Last: 8/26/2025, 8:04:00 PM
9.63 USD
0 (0%)
After Hours: 8/26/2025, 8:04:00 PM

HLN Key Statistics, Chart & Performance

Key Statistics
52 Week High11.42
52 Week Low8.86
Market Cap43.20B
Shares4.49B
Float4.48B
Yearly Dividend0.17
Dividend Yield1.86%
EPS(TTM)0.49
PE19.65
Fwd PE16.88
Earnings (Next)10-30 2025-10-30
IPO07-18 2022-07-18
Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryPharmaceuticals


HLN short term performance overview.The bars show the price performance of HLN in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 -5 -10 -15

HLN long term performance overview.The bars show the price performance of HLN in the last 1, 2 and 3 years. 1 year 2 years 3 years 0 20 40 60

The current stock price of HLN is 9.63 USD. In the past month the price decreased by -1.83%. In the past year, price decreased by -5.4%.

HALEON PLC-ADR / HLN Daily stock chart

HLN Competitors/Peers

The largest stocks on the US markets in the "Pharmaceuticals" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
LLY ELI LILLY & CO 45.57 696.62B
JNJ JOHNSON & JOHNSON 17.65 425.05B
AZN ASTRAZENECA PLC-SPONS ADR 18.03 248.19B
NVO NOVO-NORDISK A/S-SPONS ADR 14.15 245.90B
NVS NOVARTIS AG-SPONSORED ADR 14.31 245.16B
MRK MERCK & CO. INC. 11.04 212.29B
PFE PFIZER INC 7.35 141.68B
SNY SANOFI-ADR 11.33 122.68B
BMY BRISTOL-MYERS SQUIBB CO 7.01 96.09B
GSK GSK PLC-SPON ADR 8.79 80.29B
ZTS ZOETIS INC 24.89 68.60B
TAK TAKEDA PHARMACEUTIC-SP ADR 49.6 46.99B

About HLN

Company Profile

HLN logo image Haleon Plc engages in the provision of personal healthcare products. The company is headquartered in Weybridge, Surrey and currently employs 24,000 full-time employees. The company went IPO on 2022-07-18. The firm's product portfolio includes five categories, including oral health, vitamins, minerals, and supplements (VMS), pain relief, respiratory health, digestive health and others. The Company’s geographical segments include North America, Europe, Middle East, Africa, and Latin America (EMEA and LatAm, and Asia Pacific (APAC). Its respiratory health brands offer product solutions for a range of respiratory issues, including cold and flu, nasal congestion, coughs, and allergies. The firm's digestive health and other product offerings also include skin health and smoker’s health. Its oral health brands include Sensodyne, Polident, Parodontax, and Biotene. Its VMS brands include Centrum, Emergen-C, and Caltrate. Its respiratory brands include Otrivin, Theraflu, and Flonase. Its pain relief brands include Voltaren, Panadol, and Advil. Its digestive health brands include TUMS, ENO, and Fenistil.

Company Info

HALEON PLC-ADR

Building 5, First Floor, The Heights

Weybridge SURREY GB

Employees: 24561

HLN Company Website

HLN Investor Relations

Phone: 441932822000

HALEON PLC-ADR / HLN FAQ

What is the stock price of HALEON PLC-ADR today?

The current stock price of HLN is 9.63 USD. The price decreased by -0.52% in the last trading session.


What is the ticker symbol for HALEON PLC-ADR stock?

The exchange symbol of HALEON PLC-ADR is HLN and it is listed on the New York Stock Exchange, Inc. exchange.


On which exchange is HLN stock listed?

HLN stock is listed on the New York Stock Exchange, Inc. exchange.


What is the price forecast or stock price prediction for HALEON PLC-ADR stock?

26 analysts have analysed HLN and the average price target is 11.6 USD. This implies a price increase of 20.47% is expected in the next year compared to the current price of 9.63. Check the HALEON PLC-ADR stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is HALEON PLC-ADR worth?

HALEON PLC-ADR (HLN) has a market capitalization of 43.20B USD. This makes HLN a Large Cap stock.


How many employees does HALEON PLC-ADR have?

HALEON PLC-ADR (HLN) currently has 24561 employees.


What are the support and resistance levels for HALEON PLC-ADR (HLN) stock?

HALEON PLC-ADR (HLN) has a support level at 9.61 and a resistance level at 9.65. Check the full technical report for a detailed analysis of HLN support and resistance levels.


Is HALEON PLC-ADR (HLN) expected to grow?

The Revenue of HALEON PLC-ADR (HLN) is expected to decline by -1.45% in the next year. Check the estimates tab for more information on the HLN EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy HALEON PLC-ADR (HLN) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does HALEON PLC-ADR (HLN) stock pay dividends?

HALEON PLC-ADR (HLN) has a dividend yield of 1.86%. The yearly dividend amount is currently 0.17. Check the full fundamental report for a detailed analysis of HLN dividend history, reliability and sustainability.


When does HALEON PLC-ADR (HLN) report earnings?

HALEON PLC-ADR (HLN) will report earnings on 2025-10-30.


What is the Price/Earnings (PE) ratio of HALEON PLC-ADR (HLN)?

The PE ratio for HALEON PLC-ADR (HLN) is 19.65. This is based on the reported non-GAAP earnings per share of 0.49 and the current share price of 9.63 USD. Check the full fundamental report for a full analysis of the valuation metrics for HLN.


What is the Short Interest ratio of HALEON PLC-ADR (HLN) stock?

The outstanding short interest for HALEON PLC-ADR (HLN) is 0.39% of its float. Check the ownership tab for more information on the HLN short interest.


HLN Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

HLN Fundamental Analysis

ChartMill assigns a fundamental rating of 5 / 10 to HLN. While HLN belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

HLN Financial Highlights

Over the last trailing twelve months HLN reported a non-GAAP Earnings per Share(EPS) of 0.49. The EPS increased by 6.59% compared to the year before.


Industry RankSector Rank
PM (TTM) 12.84%
ROA 4.2%
ROE 8.92%
Debt/Equity 0.53
Chartmill High Growth Momentum
EPS Q2Q%N/A
Sales Q2Q%-5.33%
EPS 1Y (TTM)6.59%
Revenue 1Y (TTM)-0.61%

HLN Forecast & Estimates

26 analysts have analysed HLN and the average price target is 11.6 USD. This implies a price increase of 20.47% is expected in the next year compared to the current price of 9.63.

For the next year, analysts expect an EPS growth of 5.64% and a revenue growth -1.45% for HLN


Analysts
Analysts79.23
Price Target11.6 (20.46%)
EPS Next Y5.64%
Revenue Next Year-1.45%

HLN Ownership

Ownership
Inst Owners56.28%
Ins Owners0.06%
Short Float %0.39%
Short Ratio1.43